HOHIMER WEALTH MANAGEMENT, LLC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1802533
SEATTLE, WA
Position in ACAD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,322,540
+$279,072 QoQ
Shares Held
91,800
0.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#110
of 350 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HOHIMER WEALTH MANAGEMENT, LLC holds $8,657,709 across 7 Biotechnology names. ACAD ranks #2 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
339,100 | $4,940,687 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
91,800 | $2,322,540 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,530 | $759,996 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
1,038 | $385,793 | |
| 5 | INVA |
Innoviva, Inc.
|
9,505 | $215,858 | |
| 6 | ATYR |
aTYR PHARMA INC
|
55,000 | $32,835 | |
| 7 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
11,033 | $0 |
All Filings in ACAD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,322,540 | 91,800 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,043,468 | 91,800 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,719,078 | 101,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,172,412 | 101,800 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,542,736 | 117,883 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $2,668,263 | 160,642 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,964,534 | 161,555 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,447,465 | 159,133 | Shares | Sole | 2024-11-19 | |
| 2024-06-30 | $2,585,911 | 159,133 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $316,789 | 17,133 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $536,434 | 17,133 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $357,051 | 17,133 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $428,297 | 17,883 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $381,387 | 20,265 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $322,618 | 20,265 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $262,005 | 16,015 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $232,696 | 16,515 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $399,993 | 16,515 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $385,460 | 16,515 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $274,314 | 16,515 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $354,508 | 14,535 | Shares | Sole | 2021-07-12 | |
| 2020-12-31 | $206,622 | 3,865 | Shares | Sole | 2021-01-12 | |
| 2020-06-30 | $308,511 | 6,365 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $163,296 | 3,865 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||